How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.

Li, Xiang-Yang

How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study. [electronic resource] - Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy Jun 2010 - 308-14 p. digital

Publication Type: Clinical Trial; Journal Article

1744-9987

10.1111/j.1744-9987.2009.00783.x doi


Adult
Aged
Antimicrobial Cationic Peptides--blood
C-Reactive Protein--metabolism
Case-Control Studies
Female
Hepcidins
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology
Interleukin-6--blood
Kidney Failure, Chronic--therapy
Male
Middle Aged
Protein Precursors--blood
Renal Dialysis
Simvastatin--pharmacology
Young Adult